120 S. SIERRA AVENUE, SOLANA BEACH, CA
ClearPoint Neuro Approves Seventh Amended Incentive Compensation Plan
Reports First Quarter 2026 Results
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Results
Amended material disclosure
Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Material disclosure
Completes Acquisition of IRRAS
Q1
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Confidential Treatment Order